Review



cellulosic cartridges  (FiberCell Systems)


Bioz Verified Symbol FiberCell Systems is a verified supplier
Bioz Manufacturer Symbol FiberCell Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    FiberCell Systems cellulosic cartridges
    Cellulosic Cartridges, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 68 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cellulosic cartridges/product/FiberCell Systems
    Average 96 stars, based on 68 article reviews
    cellulosic cartridges - by Bioz Stars, 2026-04
    96/100 stars

    Images



    Similar Products

    cellulosic cartridges  (FiberCell Systems)
    96
    FiberCell Systems cellulosic cartridges
    Cellulosic Cartridges, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cellulosic cartridges/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    cellulosic cartridges - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    cellulose  (FiberCell Systems)
    96
    FiberCell Systems cellulose
    Cellulose, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cellulose/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    cellulose - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    hfim setup  (FiberCell Systems)
    96
    FiberCell Systems hfim setup
    Hfim Setup, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hfim setup/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    hfim setup - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    hollow fibre systems  (FiberCell Systems)
    96
    FiberCell Systems hollow fibre systems
    Hollow Fibre Systems, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hollow fibre systems/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    hollow fibre systems - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    cellulosic artridges  (FiberCell Systems)
    96
    FiberCell Systems cellulosic artridges
    Cellulosic Artridges, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cellulosic artridges/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    cellulosic artridges - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    hfim  (FiberCell Systems)
    96
    FiberCell Systems hfim
    Heatmap with hierarchical clustering ( A–E ) of dynamic metabolite profiles, which correlated with the total bacterial population, resistant subpopulation, and/or the log 10 -change of the total population (<-0.6 or >0.6, shaded green) of P. <t>aeruginosa</t> <t>CW41</t> challenged with ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n = 5). Metabolites notated with ** had MSI level 1 identification.
    Hfim, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hfim/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    hfim - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Heatmap with hierarchical clustering ( A–E ) of dynamic metabolite profiles, which correlated with the total bacterial population, resistant subpopulation, and/or the log 10 -change of the total population (<-0.6 or >0.6, shaded green) of P. aeruginosa CW41 challenged with ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n = 5). Metabolites notated with ** had MSI level 1 identification.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa

    doi: 10.1128/aac.01081-23

    Figure Lengend Snippet: Heatmap with hierarchical clustering ( A–E ) of dynamic metabolite profiles, which correlated with the total bacterial population, resistant subpopulation, and/or the log 10 -change of the total population (<-0.6 or >0.6, shaded green) of P. aeruginosa CW41 challenged with ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n = 5). Metabolites notated with ** had MSI level 1 identification.

    Article Snippet: A hypermutable P. aeruginosa clinical isolate, CW41, was challenged with ceftolozane-tazobactam (Zerbaxa, MSD, Australia) in the HFIM (C3008-1 cartridges; FiberCell Systems Inc., Frederick, MD, USA), in five biological replicates performed across two studies.

    Techniques: Infection

    Population model fits from the mathematical modeling of ornithine (panel B) and arginine (panel C); extracellular metabolites related to the total bacterial population of P. aeruginosa CW41 (panel A) challenged with continuous infusion (CI) regimens of ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n =5).

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa

    doi: 10.1128/aac.01081-23

    Figure Lengend Snippet: Population model fits from the mathematical modeling of ornithine (panel B) and arginine (panel C); extracellular metabolites related to the total bacterial population of P. aeruginosa CW41 (panel A) challenged with continuous infusion (CI) regimens of ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n =5).

    Article Snippet: A hypermutable P. aeruginosa clinical isolate, CW41, was challenged with ceftolozane-tazobactam (Zerbaxa, MSD, Australia) in the HFIM (C3008-1 cartridges; FiberCell Systems Inc., Frederick, MD, USA), in five biological replicates performed across two studies.

    Techniques: Infection

    Population model fits from the mathematical modeling of D-ribose 5-phosphate (panel B), trehalose 6-phosphate (panel C), and D-sedoheptulose 7-phosphate (panel D); extracellular metabolites related to the resistant subpopulation of P. aeruginosa CW41 (panel A) challenged with continuous infusion (CI) regimens of ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n = 5).

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa

    doi: 10.1128/aac.01081-23

    Figure Lengend Snippet: Population model fits from the mathematical modeling of D-ribose 5-phosphate (panel B), trehalose 6-phosphate (panel C), and D-sedoheptulose 7-phosphate (panel D); extracellular metabolites related to the resistant subpopulation of P. aeruginosa CW41 (panel A) challenged with continuous infusion (CI) regimens of ceftolozane-tazobactam (C/T) in a hollow-fiber infection model ( n = 5).

    Article Snippet: A hypermutable P. aeruginosa clinical isolate, CW41, was challenged with ceftolozane-tazobactam (Zerbaxa, MSD, Australia) in the HFIM (C3008-1 cartridges; FiberCell Systems Inc., Frederick, MD, USA), in five biological replicates performed across two studies.

    Techniques: Infection

    Parameter estimates of the mathematical models describing the relationship between measured extracellular metabolites and the bacterial pharmacodynamic data of P. aeruginosa CW41 challenged with ceftolozane-tazobactam in the hollow-fiber infection model <xref ref-type= a " width="100%" height="100%">

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa

    doi: 10.1128/aac.01081-23

    Figure Lengend Snippet: Parameter estimates of the mathematical models describing the relationship between measured extracellular metabolites and the bacterial pharmacodynamic data of P. aeruginosa CW41 challenged with ceftolozane-tazobactam in the hollow-fiber infection model a

    Article Snippet: A hypermutable P. aeruginosa clinical isolate, CW41, was challenged with ceftolozane-tazobactam (Zerbaxa, MSD, Australia) in the HFIM (C3008-1 cartridges; FiberCell Systems Inc., Frederick, MD, USA), in five biological replicates performed across two studies.

    Techniques: Infection